$ELOX Income Statement | Understand Stock

$ELOX

$13.34 +$0.17 (1.29%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
License and service revenue:
Operating expenses:
Research and development
General and administrative
In process research and development
Restructuring charges
Total operating expenses

Loss from operations
Other (income) expense, net
Provision for income taxes
Net loss
Net loss attributable to common stockholders
Change in unrealized gain (loss) on available-for-sale securities
Comprehensive loss
Net loss per share, basic and diluted
Weighted average number of shares of common stock used in computing net loss per share, basic and diluted
Net loss per share, basic
Net loss per share, diluted
Weighted average number of shares of common stock and pre-funded warrants used in computing net loss per share, basic
Weighted average number of shares of common stock and pre-funded warrants used in computing net loss per share, diluted

Comments